Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@AmericanBanking 5
@WKRBNews 2
@StockTexts 2
@macondailynews 2
@ZolmaxNews 2

Recent Tweets for EGRX

SeekingAlpha @SeekingAlpha
$EGRX - Eagle Pharmaceuticals (EGRX) Presents At RBC Capital Markets 2019 Healthcare Conference - Slideshow https://t.co/3Gmr3QXC6f
May 23rd 2019, 2:05pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/a9Y1bw3Evt
May 22nd 2019, 7:05am
omahacharts @omahacharts
Long $EGRX here and now: https://t.co/tWMVdxp1Fe
May 21st 2019, 9:05am
bulletin_en @bulletin_en
Eagle Pharmaceuticals $EGRX Valuation Declined While Dupont Capital Management Has Raised Position by $507,800; Ame… https://t.co/MzVzxM9vwy
May 21st 2019, 8:05am
macondailynews @macondailynews
Analysts Anticipate Eagle Pharmaceuticals Inc $EGRX to Announce $0.72 EPS https://t.co/8xd7KSPsDe
May 18th 2019, 11:05am
SwingTradeBot @SwingTradeBot
200 DMA Support today: $EGRX $NTWK ... https://t.co/LjP7KUcNnp
May 17th 2019, 3:05pm
ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals $EGRX Upgraded at Zacks Investment Research https://t.co/gq2Q3zf37D
May 17th 2019, 12:05pm
WKRBNews @WKRBNews
Eagle Pharmaceuticals $EGRX Upgraded at Zacks Investment Research https://t.co/VTSR9U5RQf #markets
May 17th 2019, 12:05pm
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Eagle Pharmaceuticals Inc $EGRX Will Announce Quarterly Sales of $51.33 Million https://t.co/JSi42AsmIW #stocks
May 17th 2019, 1:05am
macondailynews @macondailynews
$51.33 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/ruOqGlq2Gj
May 17th 2019, 1:05am
WatchlistN @WatchlistN
Eagle Pharmaceuticals $EGRX Upgraded to “Hold” by Zacks Investment Research https://t.co/vpBvCz60yh
May 16th 2019, 11:05am
1stOncology @1stOncology
#EaglePharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global #HealthcareConference $EGRX https://t.co/S3strwVWXe
May 16th 2019, 9:05am
AmericanBanking @AmericanBanking
Brokerages Anticipate Eagle Pharmaceuticals Inc $EGRX to Post $0.72 Earnings Per Share https://t.co/gY4VUcFMtm #stocks
May 15th 2019, 6:05pm
ProTradersNews @ProTradersNews
$EGRX: Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets …: https://t.co/rjx2u6qk8X
May 15th 2019, 4:05pm
SwingTradeBot @SwingTradeBot
200 DMA Support today: $EGRX ... https://t.co/LjP7KUcNnp
May 15th 2019, 1:05pm
stocknewstimes @stocknewstimes
Eagle Pharmaceuticals $EGRX Lifted to Hold at Zacks Investment Research https://t.co/a1vxljWYO2
May 14th 2019, 9:05am
SleekMoneycom @SleekMoneycom
Eagle Pharmaceuticals $EGRX Lifted to Hold at Zacks Investment Research https://t.co/sUet4qvzMe #investing
May 14th 2019, 9:05am
fintel_io @fintel_io
Hudson Executive Capital LP has filed an amended 13D/A, reporting 6.0% ownership in $EGRX - https://t.co/BaYZq4BjV0
May 14th 2019, 7:05am
Stock_News_Now @Stock_News_Now
$EGRX: New SEC Filing for EGRX: Form SC 13D/A (No. 0000914121-19-001251): https://t.co/WfgMvbKfKO
May 14th 2019, 7:05am
whalewisdom @whalewisdom
New SC 13D/A from HUDSON EXECUTIVE CAPITAL LP concerning $EGRX. See details at https://t.co/Uw7sLl5fR4
May 14th 2019, 6:05am
ResearchPool @ResearchPool
$EGRX #EAGLE PHARMACEUTICALS 1 director sold: A director at Eagle Pharmaceuticals Inc sold 159,223 shares at 56.813… https://t.co/TD5DJXDTH9
May 14th 2019, 6:05am
WKRBNews @WKRBNews
Insider Selling: Eagle Pharmaceuticals Inc $EGRX Director Sells 159,223 Shares of Stock https://t.co/UCtANvpqNd #markets
May 14th 2019, 4:05am
stocknewstimes @stocknewstimes
Q2 2019 Earnings Forecast for Eagle Pharmaceuticals Inc Issued By William Blair $EGRX https://t.co/UDPPNnHaV3
May 14th 2019, 2:05am
SleekMoneycom @SleekMoneycom
Q2 2019 Earnings Forecast for Eagle Pharmaceuticals Inc Issued By William Blair $EGRX https://t.co/fj04wfMRt8 #investing
May 14th 2019, 2:05am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals Inc $EGRX Director Douglas L. Braunstein Sells 159,223 Shares https://t.co/LZKQQJ28YR #stocks
May 13th 2019, 8:05pm
ZolmaxNews @ZolmaxNews
Douglas L. Braunstein Sells 159,223 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/EItLBPg89m
May 13th 2019, 8:05pm
InsiderAlertsIA @InsiderAlertsIA
$EGRX: New Insider Filing on Director DOUGLAS L BRAUNSTEIN: https://t.co/VqET6Kw3sY
May 13th 2019, 6:05pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/ZwNMrXsqqo
May 13th 2019, 5:05pm
RTFilingsStocks @RTFilingsStocks
Braunstein Douglas L files Form 4 for $EGRX Sold 159223 shares Price range: $56.14-57.95 Transaction Dates: 5/9/201… https://t.co/3dxskxOVpq
May 13th 2019, 5:05pm
AmericanBanking @AmericanBanking
Q2 2019 EPS Estimates for Eagle Pharmaceuticals Inc Lowered by William Blair $EGRX https://t.co/fIwU2SXKnv #stocks
May 13th 2019, 2:05am
dailypoliticaln @dailypoliticaln
Q2 2019 EPS Estimates for Eagle Pharmaceuticals Inc Lowered by William Blair $EGRX https://t.co/kdfCenmbyu
May 13th 2019, 2:05am
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals Inc $EGRX Shares Bought by PNC Financial Services Group Inc. https://t.co/B7Zw2RRnh1
May 12th 2019, 3:05am
bbnsnews @bbnsnews
Eagle Pharmaceuticals’ $EGRX “Hold” Rating Reaffirmed at Cantor Fitzgerald https://t.co/7AlsNk0Lgx
May 11th 2019, 12:05pm
CSIMarket @CSIMarket
$EGRX #stock #StockMarket #EaglePharmaceuticals issued on https://t.co/savSNU1XbB EGRX had impressive forth quarte… https://t.co/DnJGqmMgID
May 11th 2019, 3:05am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX – Research Analysts’ Recent Ratings Changes https://t.co/YOcW1RUGg7 #stocks
May 10th 2019, 4:05am
newswithvalue @newswithvalue
$EGRX $PZN: Hedge Funds Have Never Been More Bullish On Eagle …: https://t.co/tVMRJb9USD
May 9th 2019, 9:05pm
TickerReport @TickerReport
Eagle Pharmaceuticals Inc $EGRX Receives $69.40 Consensus Price Target from Analysts https://t.co/UFQ9Gtz3L4
May 9th 2019, 1:05pm
ChartMill @ChartMill
$EGRX: Comparing the growth rate of the last 5 years to the rate of the upcoming 2 years, we see that the growt ...… https://t.co/yylf43DGUo
May 9th 2019, 1:05pm
dailypoliticaln @dailypoliticaln
Eagle Pharmaceuticals $EGRX Given “Hold” Rating at Cantor Fitzgerald https://t.co/VzdEHTibha
May 9th 2019, 7:05am
the_chart_life @the_chart_life
$EGRX Eagle Pharma ..."Focuses on developing and commercializing injectable products primarily in the critical care… https://t.co/Vk8KmKVe59
May 8th 2019, 9:05pm
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals $EGRX Receives “Hold” Rating from Cantor Fitzgerald https://t.co/IsTWfc5K79
May 8th 2019, 10:05am
TickerReport @TickerReport
Eagle Pharmaceuticals $EGRX Announces Quarterly Earnings Results https://t.co/7cjlyqyh7n
May 8th 2019, 10:05am
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/UOvPAiViPz
May 8th 2019, 7:05am
TheMarketsDaily @TheMarketsDaily
Eagle Pharmaceuticals $EGRX Announces Earnings Results https://t.co/RchRCqGLma
May 7th 2019, 3:05pm
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX Announces Quarterly Earnings Results https://t.co/5m0Kut8yI2 #stocks
May 7th 2019, 2:05pm
SiteFocusHQ @SiteFocusHQ
$EGRX Qualitative Analysis of recent earnings identified Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) business focus o… https://t.co/vQSJXDAUt1
May 7th 2019, 2:05pm
NewsToDesk @NewsToDesk
$EGRX: Eagle Pharmaceuticals’ (EGRX) CEO Scott Tarriff on Q1 2019 …: https://t.co/HZ7CQSzBG4
May 7th 2019, 2:05pm
SeekingAlpha @SeekingAlpha
$EGRX - Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2019 Results - Earnings Call Transcript https://t.co/JhRawtrYqq
May 7th 2019, 2:05pm
StockNewsWires @StockNewsWires
$EGRX: Eagle Pharmaceuticals Inc (EGRX) Q1 2019 Earnings Call Transcript: https://t.co/yoyeaRrLLg
May 7th 2019, 12:05pm
EarningsAlley @EarningsAlley
Summary for the Eagle Pharmaceuticals, Inc. earnings call. $EGRX #earnings #EaglePharmaceuticalsInc https://t.co/RTLYR2toQf
May 7th 2019, 12:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.